Milestone deal secures UK’s medicines access for patients, with a wide range of groundbreaking new treatments to reach NHS front-line quicker.
Landmark UK-US pharmaceuticals deal to safeguard medicines access and drive vital investment for UK patients and businesses
LP Staff Writers
Writers at Lord’s Press come from a range of professional backgrounds, including history, diplomacy, heraldry, and public administration. Many publish anonymously or under initials—a practice that reflects the publication’s long-standing emphasis on discretion and editorial objectivity. While they bring expertise in European nobility, protocol, and archival research, their role is not to opine, but to document. Their focus remains on accuracy, historical integrity, and the preservation of events and individuals whose significance might otherwise go unrecorded.
Recent Posts
- WATCH: Lee Anderson erupts in Commons as school places him alongside Adolf Hitler and Benito Mussolini on ‘extreme right’ display board
- WATCH: Lee Anderson erupts in Commons as school places him alongside Adolf Hitler and Benito Mussolini on ‘extreme right’ display board
- Homes England awards £23 million infrastructure grant in latest step towards unlocking wide-scale regeneration and thousands of new homes in London
- Birmingham City Council: Ministerial response to Commissioners’ third report
- Morecambe Offshore Windfarm Generation Assets DCO decision



Follow